Robert Morlock

Articles by Robert Morlock

24 Patient Preferences for CDK4/6 Inhibitor Treatments in HR+/HER2– Early Breast Cancer: A Discrete Choice Survey Study

24 Patient Preferences for CDK4/6 Inhibitor Treatments in HR+/HER2– Early Breast Cancer: A Discrete Choice Survey Study

ByErica L. Mayer, MD, MPH,Mary Lou Smith,Annie Guérin,Dominick Latrémouille-Viau,Nisha C. Hazra,Yan Meng,Wendi Qu,Remi Bellefleur,Vaidyanathan Ganapathy,Liz Santarsiero,Robert Morlock,Maryam Lustberg

August 2nd 2024

Latest Updated Articles

Trending on CancerNetwork

FDA Approves Iberdomide Combo in Relapsed/Refractory Multiple Myeloma

Zipalertinib Combo Meets PFS End Point in First-Line EGFR Exon 20 NSCLC

Iza-Bren Yields Encouraging Activity in Extensive-Stage SCLC

How AI and Health Networks Are Democratizing Clinical Trial Access

Monitoring and Mitigating Emergent Toxicities During CAR T-Cell Therapy